Quantitative 19F NMR study of trifluorothymidine metabolism in rat brain

NMR in Biomedicine

Volumn 12, Issue 6, 1999, Pages 373-380

  Pouremad, Reza ^a   Bahk, Kenneth D ^a   Shen, Ying Jun ^a   Knop, Richard H ^a   Wyrwicz, Alice M ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Center for MR Research   (United States)

Author keywords

Brain; Fluorine 19 NMR; Rats; Trifluorothymidine; Tumor

Indexed keywords

FLUORINE; GLYCOL; THYMINE; ANTIMETABOLITE; PYRIMIDINE DERIVATIVE; THYMIDINE PHOSPHORYLASE; TRIFLUOROMETHYLURACIL; TRIFLURIDINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN METABOLISM; BRAIN TUMOR; ENZYME ACTIVITY; GLIOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RAT; SPECIES DIFFERENTIATION; ANIMAL; BRAIN; COMPARATIVE STUDY; ENZYMOLOGY; LIVER; METABOLISM; SPRAGUE DAWLEY RAT; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALIA;

ANIMALS; ANTIMETABOLITES; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; THYMIDINE PHOSPHORYLASE; TRIFLURIDINE;

EID: 0032589419     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199910)12:6<373::AID-NBM569>3.0.CO;2-R     Document Type: Article

References (22)

1. Stewart, D. J. A critique of the role of blood-brain-barrier in the chemotherapy of human brain tumors. J. Neuro-Oncol., 20, 121-139 (1994).
2. Fine, H. A. Novel biologic therapies of malignant gliomas. Neurol. Clin., 13, 827-846, (1995).
3. Heidelberger, C., Parsons, D. G. and Remy, D. C. Syntheses of 5-trifluoromethyluracil and 5-trifluoromethyl-2′-deoxyuridine. J. Am. Chem. Soc. 84, 3597-3598 (1962).
4. Heidelberger, C. and Anderson, S. W. Fluorinated pyrimidines XXI. The tumor-inhibitory activity of 5-trifluoromethyl-2′-deoxyuridine. Cancer Res., 24, 1979-1985 (1964).
5. Dexter, D. L., Wolberg, W. H., Ansfield, F. J., Helson, L. and Heidelberger, C. The clinical pharmacology of 5-trifluoromethyl-2′-deoxyuridine. Cancer Res. 32, 247-253 (1972).
6. 14C. Cancer Res., 25, 376-381 (1965).
7. 19F NMR spectroscopy. Biochem. Pharmac. 44, 2223-2228 (1992).
8. 3TdR). Biochem. Pharmac. 48, 1033-1041 (1994).
9. Haraguchi, A. V., Miyadera, K., Sumizawa, T., Furukawa, T., Yamada, K. and Akiyama, S. I. Angiogenic activity of enzymes. Nature, 368, 198 (1994).
10. Satake, H., Suzuki, N., Emura, T., Takeda, S., Wataya, Y., Yamada, Y. and Fukushima, M. A novel antitumor nucleoside, TAS-102: effect of 5-trifluorothymidine on 5-FU and 5-FdUrd-resistant tumor cells. Proc. Am. Assoc. Cancer Res. 38, 475 (1997).
11. Pouremad, R., Bahk, K. B. and Wyrwicz, A. M. The effect of trifluridine on energy metabolism and cell cycle of RG2 glioma cells in culture. Proc. Am. Assoc. Cancer Res. 38, 195 (1997).
12. Pouremad, R., Bahk, K. B. and Wyrwicz, A. M. Uptake and toxicity studies of trifluorothymidine with RG2 glioma cells. Proc. Am. Assoc. Cancer Res. 37, 407 (1996).
13. Baudisch, O. and Davidson, D. The mechanism of oxidation of thymine. 4,5-Dihydroxythymine (thymine glycol). J. Biol. Chem. 64, 233-239 (1925).
14. Fuchikami, T., Yamanouchi, A. and Ojima, I. An effective and convenient route to 5-trifluoromethyl-5,6-dihydrouracils and their thio derivatives. Synthesis, 9, 766-768 (1984).
15. 19F NMR spectroscopy. NMR Biomed. 4, 161-166 (1991).
16. Terasaki, T. and Pardridge, W. M. Restricted transport of 3′-azido-3′deoxythymidine and dideoynucleosides through the blood-brain-barrier. J. Infect. Dis., 158, 630-632 (1988).
17. Fox, S. B., Moghaddam, A., Westwood, M., Turley, H., Bicknell, R., Gater, K. C. and Harrist, A. L. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J. Pathol., 176, 183-190 (1995).
18. Moghaddam, A., Zhang, H.-T., Fan, T.-P. D., Hu, D.-E., Lees, U. C., Turley, H., Fox, S. B., Gater, K. C., Harris, A. L., Bickner, R. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl Acad. Sci., USA, 92, 998-1002 (1995).
19. Folkman, J. What is the role of thymidine phosphorylase in angiogenesis? J. Natl Cancer Inst., 88, 1091-1092 (1996).
20. Tyndale, F., Sunahare, R., Inaba, T., Kalow, W., Gonzalez, F. J., Nitznik, H. B. Neuronal cytochrome P-450 IID (debrisoquie/ sparteine-type): potent nucleoside sequence identity to human hepatic P-450 gene cypD6. Molec. Pharmac., 40, 63-68 (1991).
21. Hodgson, A. U., White, T. B. and Strobel, H. W. Expression of mixed function oxidase system in rat brain by the polymerase chain reaction. Mol. Cell. Biochem., 120, 171-179 (1993).
22. Ames, B. N., Endogenous DNA damage as related to cancer and aging. Mutat Res., 214, 41-46 (1989).